What GLP-1 Clinics Advertise: 2026 Price Report

Across 483 advertised monthly prices from 326 US clinics, the median is $239/month, and the middle half of listed prices falls between $150 and $399. These are the figures clinics publish on their websites. We do not record what each price includes, so the full program price a clinic quotes you can be higher.

Not in a way this data can settle. The median advertised clinic price for semaglutide is $206/month, against a brand-name Wegovy list price of about $1,349/month. A list price is the manufacturer's published price before insurance or discounts; Novo Nordisk also sells Wegovy pens for $349/month through its own self-pay program. And a clinic's advertised figure may not include consultations, lab work or higher doses. Compare the full program price a clinic quotes you with the manufacturer's self-pay price before deciding.

The lowest state medians in our data are Pennsylvania ($90/mo), Louisiana ($150/mo), Nebraska ($150/mo). Each state figure needs at least three listed prices, and a median of advertised prices says nothing about what a given clinic includes, so treat these as a starting point for comparison rather than a verdict on where treatment is cheapest.

Among clinics that name the medication, the median advertised price is $206/month for semaglutide and $249/month for tirzepatide. Tirzepatide is advertised slightly higher. Our data does not distinguish compounded from brand-name products.

We do not know, and you should assume not. The dataset records the price a clinic advertises, not what it covers. A starting price is the lowest tier a clinic lists, and a monthly figure may leave out the consultation, lab work, higher doses or a required program length. Where a clinic states such a condition and we have recorded it, it appears beside the price on that clinic's listing. Ask any clinic for a written full-program quote before you commit.

Prices were read from publicly listed rates on clinic websites across the United States, mostly in March 2026, with a small number re-observed in September 2026. We included monthly and starting-at prices between $50 and $1,500 and excluded per-dose, per-injection and per-visit pricing. 730 clinics in our directory publish a price of some kind; 326 of them publish one that meets those rules, and their 483 prices produce the figures on this page.

Compounded GLP-1s are made by pharmacies, not by the drug's manufacturer, and they are not FDA-approved products. The FDA declared the tirzepatide shortage over in December 2024 and the semaglutide shortage over in February 2025. Since then a state-licensed 503A pharmacy may not regularly compound what is essentially a copy of an approved drug; one exception is when the prescriber determines and documents a change that produces a significant difference for that patient, and other federal and state compounding requirements still apply. If a clinic offers a compounded version, ask why it is permitted in your case and which licensed pharmacy makes it.

Source: FDA compounding policy statement, updated April 1, 2026

It depends on the plan. Wegovy and Zepbound are FDA-approved for weight loss and some plans cover them, usually with prior authorization. Our insurance guides cover the major carriers, Medicare and Medicaid. This report has no data on what insured patients pay, so it cannot compare cash prices with copays.